Non-Saccharomyces yeasts protect against epithelial cell barrier disruption induced by Salmonella enterica subsp. enterica serovar Typhimurium

Letters in Applied Microbiology

Volumn 61, Issue 5, 2015, Pages 491-497

  Smith, I M ^a,b   Baker, A ^a   Arneborg, N ^b   Jespersen, L ^b  

^a CHR HANSEN A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Epithelial barrier; Kluyveromyces marxianus; Lactobacillus rhamnosus; Non Saccharomyces yeasts; Pathogen inhibition; Probiotics; Saccharomyces boulardii; Salmonella typhimurium; Transepithelial resistance; Yeast

Indexed keywords

CELLS; CYTOLOGY; MONOLAYERS; SALMONELLA; YEAST;

EPITHELIAL BARRIER; KLUYVEROMYCES MARXIANUS; LACTOBACILLUS RHAMNOSUS; NON-SACCHAROMYCES YEASTS; PATHOGEN INHIBITION; PROBIOTICS; SACCHAROMYCES; SACCHAROMYCES BOULARDII; SALMONELLA TYPHIMURIUM; TRANSEPITHELIAL RESISTANCE;

PATHOGENS;

PROBIOTIC AGENT;

BACTERIUM; BENCHMARKING; BIOLOGICAL INVASION; BIOTECHNOLOGY; CELLS AND CELL COMPONENTS; DIGESTIVE SYSTEM; IDENTIFICATION METHOD; INHIBITION; INVASIVE SPECIES; MICROBIOLOGY; NEW RECORD; PATHOGEN; PROBIOTICS; YEAST;

ARTICLE; BACTERIAL STRAIN; CACO 2 CELL LINE; CELL DISRUPTION; CELL FUNCTION; ELECTRIC RESISTANCE; EPITHELIAL CELL BARRIER DISRUPTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; KLUYVEROMYCES MARXIANUS; METSCHNIKOWIA; METSCHNIKOWIA GRUESSII; NONHUMAN; QUALITY CONTROL; SACCHAROMYCES BOULARDII; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; TRANSEPITHELIAL ELECTRICAL RESISTANCE; ANTIBIOSIS; IMPEDANCE; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; KLUYVEROMYCES; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SACCHAROMYCES; SALMONELLA INFECTIONS; TIGHT JUNCTION;

KLUYVEROMYCES MARXIANUS; LACTOBACILLUS RHAMNOSUS; METSCHNIKOWIA GRUESSII; SACCHAROMYCES; SACCHAROMYCES BOULARDII; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

ANTIBIOSIS; CACO-2 CELLS; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; KLUYVEROMYCES; METSCHNIKOWIA; PROBIOTICS; SACCHAROMYCES; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; TIGHT JUNCTIONS;

EID: 84944075349     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/lam.12481     Document Type: Article

References (33)

1. Badia, R., Brufau, M.T., Guerrero-Zamora, A.M., Lizardo, R., Dobrescu, I., Martin-Venegas, R., Ferrer, R., Salmon, H. et al. (2012) β-galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar typhimurium in porcine intestinal epithelial and dendritic cells. Clin Vaccine Immunol 19, 368-376.
2. Canonici, A., Pellegrino, E., Siret, C., Terciolo, C., Czerucka, D., Bastonero, S., Marvaldi, J., Lombardo, D. et al. (2012) Saccharomyces boulardii improves intestinal epithelial cell restitution by inhibiting αvβ5 integrin activation state. PLoS ONE 7, e45047.
3. Clayburgh, D.R., Shen, L. and Turner, J.R. (2004) A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 84, 282-291.
4. Czerucka, D., Dahan, S., Mograbi, B., Rossi, B. and Rampal, P. (2000) Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 68, 5998-6004.
5. Edwards-Ingram, L., Gitsham, P., Burton, N., Warhurst, G., Clarke, I., Hoyle, D., Oliver, S.G. and Stateva, L. (2007) Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae. Appl Environ Microbiol 73, 2458-2467.
6. Fang, H.W., Fang, S.B., Chiang Chiau, J.S., Yeung, C.Y., Chan, W.T., Jiang, C.B., Cheng, M.L. and Lee, H.C. (2010) Inhibitory effects of Lactobacillus casei subsp. rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells. J Med Microbiol 59, 573-579.
7. Gagnon, M., Zihler Berner, A., Chervet, N., Chassard, C. and Lacroix, C. (2013) Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion. J Microbiol Methods 94, 274-279.
8. Gedek, B.R. (1999) Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 42, 261-264.
9. Haraga, A., Ohlson, M.B. and Miller, S.I. (2008) Salmonellae interplay with host cells. Nat Rev Microbiol 6, 53-66.
10. Jepson, M.A., Collares-Buzato, C.B., Clark, M.A., Hirst, B.H. and Simmons, N.L. (1995) Rapid disruption of epithelial barrier function by Salmonella typhimurium is associated with structural modification of intercellular junctions. Infect Immun 63, 356-359.
11. Klingberg, T.D., Pedersen, M.H., Cencic, A. and Budde, B.B. (2005) Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity. Appl Environ Microbiol 71, 7528-7530.
12. Klingberg, T.D., Lesnik, U., Arneborg, N., Raspor, P. and Jespersen, L. (2008) Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits. FEMS Yeast Res 8, 631-640.
13. Kumura, H., Tanoue, Y., Tsukahara, M., Tanaka, T. and Shimazaki, K. (2004) Screening of dairy yeast strains for probiotic applications. J Dairy Sci 87, 4050-4056.
14. Lebeer, S., Vanderleyden, J. and De Keersmaecker, S.C. (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8, 171-184.
15. Maccaferri, S., Klinder, A., Brigidi, P., Cavina, P. and Costabile, A. (2012) Potential probiotic Kluyveromyces marxianus B0399 modulates the immune response in Caco-2 cells and peripheral blood mononuclear cells and impacts the human gut microbiota in an in vitro colonic model system. Appl Environ Microbiol 78, 956-964.
16. Mankertz, J. and Schulzke, J.D. (2007) Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 23, 379-383.
17. Martins, F.S., Rodrigues, A.C., Tiago, F.C., Penna, F.J., Rosa, C.A., Arantes, R.M., Nardi, R.M., Neves, M.J. et al. (2007) Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol 56, 352-359.
18. Martins, F.S., Dalmasso, G., Arantes, R.M., Doye, A., Lemichez, E., Lagadec, P., Imbert, V., Peyron, J.F. et al. (2010) Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection. PLoS ONE 5, e8925.
19. Mennigen, R., Nolte, K., Rijcken, E., Utech, M., Loeffler, B., Senninger, N. and Bruewer, M. (2009) Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 296, G1140-G1149.
20. Pedersen, L.L., Owusu-Kwarteng, J., Thorsen, L. and Jespersen, L. (2012) Biodiversity and probiotic potential of yeasts isolated from Fura, a West African spontaneously fermented cereal. Int J Food Microbiol 159, 144-151.
21. Peterson, L.W. and Artis, D. (2014) Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 14, 141-153.
22. Pontier-Bres, R., Prodon, F., Munro, P., Rampal, P., Lemichez, E., Peyron, J.F. and Czerucka, D. (2012) Modification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardii. PLoS ONE 7, e33796.
23. Romanin, D., Serradell, M., Gonzalez Maciel, D., Lausada, N., Garrote, G.L. and Rumbo, M. (2010) Down-regulation of intestinal epithelial innate response by probiotic yeasts isolated from kefir. Int J Food Microbiol 140, 102-108.
24. Saegusa, S., Totsuka, M., Kaminogawa, S. and Hosoi, T. (2007) Cytokine responses of intestinal epithelial-like Caco-2 cells to non-pathogenic and opportunistic pathogenic yeasts in the presence of butyric acid. Biosci Biotechnol Biochem 71, 2428-2434.
25. Seth, A., Yan, F., Polk, D.B. and Rao, R.K. (2008) Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 294, G1060-G1069.
26. Smith, I.M., Christensen, J.E., Arneborg, N. and Jespersen, L. (2014) Yeast modulation of human dendritic cell cytokine secretion: an in vitro study. PLoS ONE 9, e96595.
27. Sultana, R., McBain, A.J. and O'Neill, C.A. (2013) Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates. Appl Environ Microbiol 79, 4887-4894.
28. Suzuki, T. (2013) Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 70, 631-659.
29. Tiago, F.C.P., Martins, F.S., Rosa, C.A., Nardi, R.M.D., Cara, D.C. and Nicoli, J.R. (2009) Physiological characterization of non-Saccharomyces yeasts from agro-industrial and environmental origins with possible probiotic function. World J Microbiol Biotechnol 25, 657-666.
30. Tiago, F.C.P., Martins, F.S., Souza, E.L.S., Pimenta, P.F.P., Araujo, H.R.C., Castro, I.M., Brandão, R.L. and Nicoli, J.R. (2012) Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. J Med Microbiol 61, 1194-1207.
31. Turner, J.R. (2009) Intestinal mucosal barrier function in health and disease. Nat Rev 9, 799-809.
32. Van der Aa Kühle, A. and Jespersen, L. (2003) The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene. Syst Appl Microbiol 26, 564-571.
33. Zihler, A., Gagnon, M., Chassard, C. and Lacroix, C. (2011) Protective effect of probiotics on Salmonella infectivity assessed with combined in vitro gut fermentation-cellular models. BMC Microbiol 11, 264.